Bright Minds Biosciences Inc. announced that it will receive $54,160 in funding on March 22, 2024. The company will issue share purchase options in the transaction. The company will issue securities pursuant to exemption provided under Regulation D. Each Option is exercisable to purchase one common share of the Company at $1.84 for a period of 5 years from the date of grant.